Clinical Trials for Chronic Myelomonocytic Leukemia-1

Find clinical trials for chronic myelomonocytic leukemia-1. Discover research opportunities and treatment options in your area.

3 Active Trials Found

Showing 3 trials on this page

Page 1 of 1

Phase I/II Study of Tagraxofusp in Combination With Decitabine for Patients With Myelomonocytic/Myeloproliferative Neoplasm and High Risk Myelodysplastic Syndromes

NCT ID: NCT05038592

This clinical trial is investigating a new treatment for a type of blood cancer called Chronic Myelomonocytic Leukemia (CMML). The treatment combines two medications: tagraxofusp, which targets and...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States

Seclidemstat and Azacitidine for the Treatment of Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

NCT ID: NCT04734990

This clinical trial is studying a new treatment combination for patients with myelodysplastic syndrome (MDS) and chronic myelomonocytic leukemia (CMML). The researchers want to find out the best do...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States

A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)

NCT ID: NCT06950034

This clinical trial is studying a new treatment called STX-0712 for patients with advanced forms of blood cancers known as Chronic Myelomonocytic Leukemia (CMML) and Acute Myeloid Leukemia (AML). T...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions